Theralase Technologies Inc. (TLT) Company Profile

Theralase Technologies Inc. Company Snapshot

Theralase Technologies Inc. operates within the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Theralase Technologies Inc. with three other companies in this sector in Canada: SQI Diagnostics Inc. (2017 sales of 968,000.00 Canadian Dollars [US$731,120.72 ] ), MedX Health Corp. (1.09 million Canadian Dollars [US$825,712.48 ] ), and Simavita Ltd (928,497.70 Canadian Dollars [US$701,285.03 ] ).

Sales Analysis. During the year ended December of 2017, sales at Theralase Technologies Inc. were C$2.34 million (US$1.77 million). This is an increase of 22.1% versus 2016, when the company's sales were C$1.92 million.

Theralase Technologies Inc.

Stock Data:

Recent Stock Performance:

Current Price (11/9/2018): .35
(Figures in Canadian Dollars)

1 Week	13.1%	13 Weeks	4.5%

4 Weeks	-11.5%	52 Weeks	40.8%

Theralase Technologies Inc. Key Data:

Ticker:	TLT	Country:	Canada

Exchanges:	VEN	Major Industry:	Health Care Equipment & Services

		Sub Industry:	Electromedical Equipment

2017 Sales	2,342,508 (Year Ending Jan 2018).	Employees:	N/A

Currency:	Canadian Dollars	Market Cap:	45,397,006

Fiscal Yr Ends:	December	Shares Outstanding:	131,585,526

Share Type:		Closely Held Shares:	7,706,963

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.